Status:

COMPLETED

Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.

Lead Sponsor:

University of Florence

Conditions:

Hypoactive Sexual Desire Disorder

Vulvovaginal Disease

Eligibility:

FEMALE

18+ years

Brief Summary

The regulation of clitoral vascularization by sex steroids is still under-investigated. We aimed to explore the effects of 6 months transdermal Testosterone (T) therapy on clitoral color Doppler ultra...

Detailed Description

Strong clinical evidence supports the use of transdermal systemic testosterone (T) treatment for Hypoactive Sexual Desire Disorder (HSDD) in menopausal women. According to preclinical studies, T is ne...

Eligibility Criteria

Inclusion

  • being heterosexual.

Exclusion

  • history of drug or alcohol abuse
  • a diagnosis of uncontrolled or unstable mental or organic disease.

Key Trial Info

Start Date :

March 20 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2020

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT04336891

Start Date

March 20 2019

End Date

March 31 2020

Last Update

April 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Andrology, Women's Endocrinology and Gender Incongruence Unit, University of Florence, Azienda Ospedaliero-Universitaria Careggi

Florence, Italy, 50136